Brief: Hansa Biopharma Q4 Net Income SEK -276.4 Million
06/02/2025 06:00
Feb 06 (Reuters) - Hansa Biopharma Q4 adjusted EPS SEK -4.08. * Q4 revenue SEK 32.3 million * Q4 EBIT SEK -173.7 million * Q4 cash & investments SEK 405.3 million
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS